Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

QIAGEN DNA Synthesis AB

Closing information (x1000 EUR)

Closing information 2022/12 2021/12 2020/12
Turnover 7,050 More Arrow 8,365 More Arrow 12,971
Financial expenses 446 Less Arrow 238 Less Arrow 161
Earnings before taxes -4,781 More Arrow -3,178 More Arrow -740
EBITDA -3,614 More Arrow -2,230 More Arrow -183
Total assets 14,335 Less Arrow 13,925 More Arrow 14,873
Current assets 8,074 Less Arrow 7,241 More Arrow 7,624
Current liabilities 12,630 More Arrow 12,734 Less Arrow 10,145
Equity capital 1,705 Less Arrow 1,190 More Arrow 4,728
- share capital 18 More Arrow 20 Equal arrow 20
Employees (average) 105 Less Arrow 97 Less Arrow 91

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 11.9% Less Arrow 8.5% More Arrow 31.8%
Turnover per employee 67 More Arrow 86 More Arrow 143
Profit as a percentage of turnover -67.8% More Arrow -38.0% More Arrow -5.7%
Return on assets (ROA) -30.2% More Arrow -21.1% More Arrow -3.9%
Current ratio 63.9% Less Arrow 56.9% More Arrow 75.2%
Return on equity (ROE) -280.4% More Arrow -267.1% More Arrow -15.7%
Change turnover -637 Less Arrow -4,366 More Arrow 4,547
Change turnover % -8% Less Arrow -34% More Arrow 54%
Chg. No. of employees 8 Less Arrow 6 More Arrow 19
Chg. No. of employees % 8% Less Arrow 7% More Arrow 26%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.